Literature DB >> 22749579

Immunolocalization of DCAMKL-1, a putative intestinal stem cell marker, in normal colonic tissue.

Giuseppe Gagliardi1, Krzysztof Moroz, Charles F Bellows.   

Abstract

Doublecortin and CaM kinase-like-1 (DCAMKL-1) is a microtubule-associated protein kinase which has been recently proposed as a gastrointestinal stem cell marker. The aim of our study was to characterize DCAMKL-1 expression in normal human colon by immunohistochemistry. DCAMKL-1 immunostaining was performed on histologically normal colorectal biopsies from 14 patients. Immunoreactivity was found in over 60% of colonic crypts and was represented by strong cytoplasmic staining, anti-luminal in distribution, and was reminiscent of cytoplasmic orientation of neuroendocrine cells. The highest number (48.5%) of DCAMKL-1 positive cells was found in the first 4 cells from the crypt base. Seventy percent of DCAMKL-1 positive cells were located in the lower third of the crypt, 26% in the middle third and 4% in the upper third. Therefore, in normal colonic mucosa, expression of DCAMKL-1 is not confined to the stem cell compartment. When we compared DCAMKL-1 immunostaining with that of the leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5), an intestinal stem cell marker, and chromogranin-A (CgA), an enteroendocrine cell marker, we found that DCAMKL-1 positive cells co-stained with Lgr5 only at the crypt base, but co-stained with CgA throughout the crypt. Our findings suggest that DCAMKL-1 marks a subset of colorectal stem cells, as well as a subset of enteroendocrine cells. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749579     DOI: 10.1016/j.prp.2012.05.015

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  16 in total

1.  Suppression of intestinal tumorigenesis in Apc mutant mice upon Musashi-1 deletion.

Authors:  Andy R Wolfe; Amanda Ernlund; William McGuinness; Carl Lehmann; Kaitlyn Carl; Nicole Balmaceda; Kristi L Neufeld
Journal:  J Cell Sci       Date:  2017-01-12       Impact factor: 5.285

Review 2.  Dclk1-expressing tuft cells: critical modulators of the intestinal niche?

Authors:  Moritz Middelhoff; C Benedikt Westphalen; Yoku Hayakawa; Kelley S Yan; Michael D Gershon; Timothy C Wang; Michael Quante
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-06       Impact factor: 4.052

3.  Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.

Authors:  Lorenz Kadletz; Klaus Aumayr; Gregor Heiduschka; Sven Schneider; Elisabeth Enzenhofer; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-28       Impact factor: 2.503

4.  Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications.

Authors:  Pomila Singh; Malaney O'Connell; Sarkar Shubhashish
Journal:  Stem Cell Investig       Date:  2016-09-28

5.  DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.

Authors:  Tianbo Gao; Min Wang; Lingling Xu; Tao Wen; Jian Liu; Guangyu An
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-12       Impact factor: 4.553

6.  Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.

Authors:  Lianna Li; Charles F Bellows
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

7.  Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.

Authors:  Naveen K Neradugomma; Dharmalingam Subramaniam; Ossama W Tawfik; Vincent Goffin; T Rajendra Kumar; Roy A Jensen; Shrikant Anant
Journal:  Carcinogenesis       Date:  2013-11-21       Impact factor: 4.944

8.  DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.

Authors:  Aki Takiyama; Toshiaki Tanaka; Shinsuke Kazama; Hiroshi Nagata; Kazushige Kawai; Keisuke Hata; Kensuke Otani; Takeshi Nishikawa; Kazuhito Sasaki; Manabu Kaneko; Shigenobu Emoto; Koji Murono; Hirotoshi Takiyama; Hiroaki Nozawa
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

9.  Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

Authors:  Malaney R O'Connell; Shubhashish Sarkar; Gurinder K Luthra; Yoshinaga Okugawa; Yuji Toiyama; Aakash H Gajjar; Suimin Qiu; Ajay Goel; Pomila Singh
Journal:  Sci Rep       Date:  2015-10-08       Impact factor: 4.379

10.  Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1.

Authors:  Andrew Fesler; Hua Liu; Jingfang Ju
Journal:  Oncotarget       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.